https://scholars.lib.ntu.edu.tw/handle/123456789/529739
標題: | The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease | 作者: | Kim H.K. Tantry U.S. Smith S.C. Jeong M.H. Park S.-J. Kim M.H. Lim D.-S. Shin E.-S. Park D.-W. Huo Y. Chen S.-L. Bo Z. Goto S. Kimura T. Yasuda S. WEN-JONE CHEN Chan M. Aradi D. Geisler T. Gorog D.A. Sibbing D. Lip G.Y.H. Angiolillo D.J. Gurbel P.A. Jeong Y.-H. |
關鍵字: | antiplatelet therapy; bleeding risk; direct oral anticoagulants; ischemic risk; race | 公開日期: | 2020 | 來源出版物: | Thrombosis and Haemostasis | 摘要: | East Asian patients have reduced anti-ischemic benefits and increased bleeding risk during antithrombotic therapies compared with Caucasian patients. As potent P2Y 12 receptor inhibitors (e.g., ticagrelor and prasugrel) and direct oral anticoagulants are commonly used in current daily practice, the unique risk-benefit trade-off in East Asians has been a topic of emerging interest. In this article, we propose updated evidence and future directions of antithrombotic treatment in East Asian patients. ? 2020. Thieme. All rights reserved. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/529739 | ISSN: | 0340-6245 | DOI: | 10.1055/s-0040-1718729 | SDG/關鍵字: | acetylsalicylic acid; anticoagulant agent; antithrombin; apixaban; blood clotting factor 5; blood clotting factor 7; blood clotting factor 8; C reactive protein; clopidogrel; D dimer; dabigatran; edoxaban; endothelial leukocyte adhesion molecule 1; fibrinogen; prasugrel; prothrombin; rivaroxaban; ticagrelor; von Willebrand factor; warfarin; acute coronary syndrome; atrial fibrillation; bleeding risk score; blood clotting; brain hemorrhage; cardiovascular disease; carotid artery disease; Caucasian; clinical outcome; clinical study; comorbidity; deep vein thrombosis; drug dose reduction; drug withdrawal; dual antiplatelet therapy; East Asian; endothelial dysfunction; ethical dilemma; ethnicity; gene mutation; Helicobacter pylori; human; ischemia; meta analysis (topic); monotherapy; mortality; randomized controlled trial (topic); Review; thrombophilia |
顯示於: | 醫學院附設醫院 (臺大醫院) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。